Scientists track cancer Drug's journey through the body
NCT ID NCT06308263
Summary
This early-stage study aims to understand how the body processes the experimental cancer drug tuvusertib. It will enroll 12 adults with advanced solid tumors to track how the drug is absorbed, broken down, and eliminated. The main goal is to gather detailed information about the drug's behavior in the body and its safety, not to test its effectiveness against cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Pharmaceutical Research Associates Magyarország Kutatás - Fejlesztési Kft., Klinikai Farmakológiai Vizsgálóhely
Budapest, Hungary
Conditions
Explore the condition pages connected to this study.